Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors

Hashmat Sikder1, David L Huso, Hong Zhang

  • 1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

Cancer Cell
|October 31, 2003
PubMed

Insights

Loss of Id1 protein increases susceptibility to skin tumors in mice, with fewer T cells but no change in tumor angiogenesis. This suggests differences in tumor development mechanisms.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Id genes, including Id1, play a role in regulating tumor angiogenesis.
  • Loss of Id1 has been shown to inhibit tumor xenograft growth in mice.

Purpose of the Study:

  • To evaluate the role of Id1 in a more clinically relevant skin tumor model using chemical carcinogenesis.
  • To investigate the impact of Id1 deficiency on skin tumorigenesis, proliferation, angiogenesis, and immune cell populations.

Main Methods:

  • Utilized a two-step chemical carcinogenesis protocol in Id1 knockout (Id1-/-) and wild-type mice.
  • Assessed tumor susceptibility, proliferation, and angiogenesis in cutaneous neoplasms.
  • Quantified cutaneous gammadelta T cell populations and investigated chemokine receptor expression (CXCR4).

Main Results:

  • Id1-/- mice exhibited increased susceptibility to skin tumorigenesis compared to wild-type counterparts.
  • Cutaneous neoplasms in Id1-/- mice showed increased proliferation but no significant alterations in tumor angiogenesis.
  • Id1-/- mice had 50% fewer cutaneous gammadelta T cells, linked to a migration defect from CXCR4 downregulation.

Conclusions:

  • Id1 plays a protective role against chemical-induced skin tumorigenesis.
  • Differences exist in angiogenesis mechanisms between transplanted and autochthonous tumors.
  • Findings have implications for the efficacy of antiangiogenic therapies in cancer treatment.